Nucleoside reverse transcriptase inhibitors (NRTIs)

D 70 Pill - white capsule-shape, 16mm

Pill with imprint D 70 is White, Capsule-shape and has been identified as Didanosine Delayed Release 125 mg. It is supplied by Aurobindo Pharma.

Didanosine is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Didanosine (Didanosine [ dye-dan-oh-seen ])-D 70-125 mg-White-Capsule-shape

Didanosine
Generic Name: didanosine [ dye-dan-oh-seen ]
Imprint: D 70
Strength: 125 mg
Color: White
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 65862-0310 (Discontinued)
Inactive Ingredients: Sodium starch glycolate type A potato, Carboxymethylcellulose sodium, Sodium lauryl sulfate, Hypromellose 2910 (3 mPa.s), Magnesium silicate, Methacrylic acid - ethyl acrylate copolymer (1:1) type a, Diethyl phthalate, Silicon dioxide, Gelatin, Titanium dioxide, Ferrosoferric oxide, Shellac,
Latest News
Related Drugs